STAT

NSF testing new Ph.D. model giving trainees academic and industry experience

Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic ...
STAT

Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemption

Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...
STAT

Fauci invokes Fifth Amendment in declining to answer questions before Senate panel

At a highly anticipated Senate hearing, Anthony Fauci evoked his Fifth Amendment right to refuse to answer questions about ...
STAT

Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx

Latigo Biotherapeutics published positive data for an acute-pain drug meant to rival a Vertex medicine already on the market ...
STAT

End of Medicare drug subsidy gives Democrats new attack line on rising out-of-pocket costs

The White House decision to end a Medicare drug subsidy plays into Democratic arguments ahead of the midterms.
STAT

Hims misled consumers and violated their privacy, FTC alleges in a lawsuit

The U.S. Federal Trade Commission sued telehealth company Hims & Hers alleging business practices that agency says misled ...
STAT

FDA expert panel recommends against approval of Capricor’s Duchenne drug

STAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has been the ...
STAT

A neglected issue in pedestrian, biker deaths

While politicians call for Fauci to be jailed, STAT’s Adam Feuerstein has an extensive follow-up story on biotech’s ...
STAT

Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more

The discovery that a fugitive had been working under an alias in the biotech industry prompted a question: How did he evade ...
STAT

Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated

You might recall that in mid-June, there was a Nature Medicine study that pitted clinical AI systems OpenEvidence and ...
STAT

Tracking the FDA expert review of Replimune’s melanoma treatment

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
STAT

Parabilis Medicines raises $305 million as CEO warms to an IPO

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...